Editorial Policies

Focus and Scope

Clinical and Pharmaceutical Sciences Journal (CliPs) utilizes contributions from academics and practitioner-researchers on Clinical and Pharmaceutical Sciences. CliPs publishes original research work on all aspects of Clinical and Pharmaceutical Sciences.

The journal encourages rigorous, substantial, and original research on any topic related to health and pharmaceutical sciences, within or across disciplines. Clinical and Pharmaceutical Sciences Journal accepts scientific papers in the form of research reports (original article research papers), systematic review, and meta analysis with focus and scope : pharmaceutical technology, pharmacology and toxicology, pharmaceutical chemistry, pharmaceutical biology, clinical and community of pharmacy,   pharmacoeconomy, pharmacoepidemiology, pharmaceutical care, management of pharmacy, biopharmaceutics, pharmaceutical microbiology and biotechnology, pharmacokinetics, alternative medicines, cosmetic technology, health policy, medicine (miscellaneous), public health, environmental and occupational health, and nursing.

This journal provides an innovative platform for researchers, students, practitioners, and educators to learn and contribute to this field. All articles must undergo initial Editorial screening and then undergo a rigorous double-blind peer review process before publication.

Section Polices

Articles

Checked Open Submissions        Checked Indexed Checked Peer Reviewed

Signal Processing

Editors

  • Lolita
Checked Open Submissions        Checked Indexed Checked Peer Reviewed

Image Processing

Editors

  • Azis Ikhsanudin
Checked Open Submissions        Checked Indexed Checked Peer Reviewed

Peer Review Process

An editor first reviews the submitted manuscript. It will be evaluated in the office whether it is suitable for the The Health and Pharmaceutical Sciences International Journal focus and scope or has a major methodological flaw and similarity score by using iThenticate.

The manuscript will be sent to at least two anonymous reviewers (Double-Blind Peer Review). Reviewers' comments are then sent to the corresponding author for necessary actions and responses.

The suggested decision will be evaluated in an editorial board meeting. Afterwards, the editor will send the final decision to the corresponding author.

Open Access Policy

This journal is an open-access journal that provides immediate, worldwide, barrier-free access to the full text of all published articles without charge readers or their institutions for access. Readers have the right to read, download, copy, distribute, print, search, or link to the full texts of all articles in the The Health and Pharmaceutical Sciences International Journal. This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Publication Ethics and Malpractice Statement

Section A: Publication and autoship

  1. All submitted papers are subject to a strict peer-review process by at least two international reviewers that are experts in the area of the particular article.
  2. The review process is a blind peer review.
  3. The factors that are taken into account in the review are relevance, soundness, significance, originality, readability, and language.
  4. The possible decisions include acceptance, acceptance with revisions, or rejection.
  5. If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised bid will be accepted.
  6. Rejected articles will not be re-reviewed.
  7. The paper acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement, and plagiarism.
  8. No research can be included in more than one publication.

Section B: Authors’ responsibilities

  1. Authors must certify that their manuscripts are their original work.
  2. Authors must certify that the manuscript has not previously been published elsewhere.
  3. Authors must certify that the manuscript is not currently being considered for publication elsewhere. 
  4. Authors must participate in the peer-review process. 
  5. Authors are obliged to provide retractions or corrections of mistakes.
  6. All Authors mentioned in the paper must have significantly contributed to the research.
  7. Authors must state that all data in the paper are real and authentic.
  8. Authors must notify the Editors of any conflicts of interest.
  9. Authors must identify all sources used in the creation of their manuscript.
  10. Authors must report any errors they discover in their published paper to the Editors. 

Section C: Reveiwer’s responsibilities

  1. Reviewers should keep all information regarding papers confidential and treat them as privileged information. 
  2. Reviews should be conducted objectively, with no personal criticism of the author
  3. Reviewers should express their views clearly with supporting arguments
  4. Reviewers should identify relevant published work that has not been cited by the authors.
  5. Reviewers should also call to the Editor in Chief’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
  6. Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Section D: Editor’s responsibilities

  1. Editors have complete responsibility and authority to reject/accept an article.
  2. Editors are responsible for the contents and overall quality of the publication.
  3. Editors should always consider the needs of the authors and the readers when attempting to improve the publication.
  4. Editors should guarantee the quality of the papers and the integrity of the academic record.
  5. Editors should publish errata pages or make corrections when needed.
  6. Editors should have a clear picture of the research’s funding sources.
  7. Editors should base their decisions solely one the papers’ importance, originality, clarity, and relevance to the publication’s scope.
  8. Editors should not reverse their decisions nor overturn the ones of previous editors without serious reason. 
  9. Editors should preserve the anonymity of reviewers. 
  10. Editors should ensure that all research material they publish conforms to internationally accepted ethical guidelines.
  11. Editors should only accept a paper when reasonably sure.
  12. Editors should act if they suspect misconduct, whether a paper is published or unpublished, and make all reasonable attempts to persist in obtaining a resolution to the problem.
  13. Editors should not reject papers based on suspicions; they should have proof of misconduct.
  14. Editors should not allow any conflicts of interest between staff, authors, reviewers, and board members.